A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give thioctic acid and
deprenyl (selegiline hydrochloride), alone or in combination, to HIV-infected patients who
have mild to moderate dementia (a decline in their mental abilities).